OneSkin
SAN FRANCISCO, CA · Biotechnology · 50 employees
OneSkin is a longevity company on a mission to transform the way we think about skin and aging. Founded by a team of four female PhDs, OneSkin’s products focus on skin longevity. OneSkin’s proprietary peptide, OS-01, is the first ingredient designed to reduce skin's biological age by improving skin barrier, supporting DNA damage repair, and preventing the accumulation of aged cells.
Funding history
- Funding Round — $20.0M — Aug 2025
- Funding Round — $20.4M — Jun 2025
- Funding Round — $7.0M — Oct 2024
- Funding Round — $12.4M — Oct 2022
Recent signals
- Aug 08, 2025: Raised $20.0M
- Jun 12, 2025: Raised $20.4M
- Oct 03, 2024: Raised $7.0M
- Oct 27, 2022: Raised $12.4M
See plans & pricing → Track OneSkin’s funding, hiring, and signals — with verified contacts — on Fundz.